Debevoise Advises Nestlé in Agreement to Acquire Aesthetic Dermatology Assets for $1.4 Billion
Debevoise & Plimpton LLP is advising Nestlé S.A. in its agreement to acquire from Valeant Pharmaceuticals, for $ 1.4 billion in cash, several key aesthetic dermatology products in the U.S. and Canada. North America represents more than half of the world’s fast-growing medical aesthetics market. The assets will reside within Nestlé’s Skin Health division, […]